Cargando…

ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA

Detalles Bibliográficos
Autores principales:	KUMAR, MYTHRI ANIL, SINGHA, MEHER, MCLAUGHLIN, TARA, PARIKH, RAJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:	Chest Infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548820/ http://dx.doi.org/10.1016/j.chest.2022.08.439

Ejemplares similares

COST ANALYSIS FOR USE OF PROCALCITONIN AND INFLAMMATORY MARKERS IN COVID-19 VENTILATOR-ASSOCIATED PNEUMONIA
por: KIM, A., et al.
Publicado: (2022)

PROCALCITONIN AS A PREDICTOR OF CLINICAL OUTCOMES IN PATIENTS WITH COVID-19
por: JACKSON, IAN, et al.
Publicado: (2021)

UPFRONT COMMUNITY-ACQUIRED PNEUMONIA ANTIMICROBIAL THERAPY IS ASSOCIATED WITH REDUCED RATES OF VENTILATOR-ASSOCIATED PNEUMONIA IN PATIENTS WITH COVID-19
por: WAKEFIELD, CONNOR, et al.
Publicado: (2022)

PATIENTS WITH MODERATE COVID-19: COMPARISON OF PROCALCITONIN SERUM LEVEL IN TWO GROUPS WITH DIFFERENT CHEST IMAGING FINDINGS
por: SHAFIEPOUR, M., et al.
Publicado: (2022)

BASELINE CHARACTERISTICS AND PREDICTORS FOR ALL-CAUSE MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA
por: CHAROENPONG, PRANGTHIP, et al.
Publicado: (2021)

LETHAL FUNGEMIA IN COVID-19 PNEUMONIA
por: PLEMMONS, ANNA, et al.
Publicado: (2021)

POST-COVID-19 EOSINOPHILIC PNEUMONIA
por: SHAH, DHIRAJ, et al.
Publicado: (2022)

MARKEDLY ELEVATED TROPONIN WITH COVID-19 PNEUMONIA WITHOUT ACUTE CORONARY SYNDROME
por: KUMAR, DILEEP, et al.
Publicado: (2021)

IMPACT OF ADMISSION TROPONIN AND TROPONIN RISE DURING HOSPITALIZATION ON MORTALITY IN COVID-19 PNEUMONIA WITH ACUTE RESPIRATORY FAILURE
por: GUPTA, MANASVI, et al.
Publicado: (2021)

VIRAL RESPIRATORY INFECTIONS AS A CONTRIBUTING FACTOR IN COMMUNITY-ACQUIRE PNEUMONIA IN EGYPTIAN PATIENTS/SINGLE CENTER EXPERIENCE/CAIRO UNIVERSITY HOSPITALS (CUH) 2010-2014
por: Elhassan, Usama Abu
Publicado: (2020)

THE MULBSTA SCORE: PREDICTING RISK OF MORTALITY AND DISEASE SEVERITY IN PATIENTS WITH COVID-19 PNEUMONIA
por: Tusha, Jurgena, et al.
Publicado: (2020)

CLINICAL OUTCOMES OF PATIENTS WITH ASTHMA WITH COVID-19 PNEUMONIA
por: Brinton, Taylor, et al.
Publicado: (2020)

RESTRICTIVE LUNG DEFECT IN POST-COVID-19 PNEUMONIA
por: TAWEESEDT, PAHNWAT, et al.
Publicado: (2021)

LEAKY LUNGS: A COMPLICATION OF COVID-19 PNEUMONIA
por: ADHIKARI, PRAKASH, et al.
Publicado: (2021)

NOT EVERYTHING IS COVID: PERSISTENT FEVER AND MALAISE MIMICKING COVID-19 PNEUMONIA
por: ATUAKA, CHRISTIANA, et al.
Publicado: (2021)

GUILLAIN-BARRÉ SYNDROME FOLLOWING COVID-19 PNEUMONIA: ARE THEY RELATED?
por: THOMAS, AKESH, et al.
Publicado: (2021)

UNEXPECTED OPPORTUNISTIC INFECTION IN PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: NIEVES, HÉCTOR, et al.
Publicado: (2021)

DEXAMETHASONE-INDUCED HICCUPS IN A PATIENT WITH COVID-19 PNEUMONIA
por: HASIB KHALIL, MUHAMMAD
Publicado: (2021)

ROSEOMONAS GILARDII-ASSOCIATED BACTEREMIA IN THE SETTING OF COVID-19 PNEUMONIA
por: NANGRANI, KUNAL, et al.
Publicado: (2021)

ABO BLOOD TYPES AND INFLAMMATORY MARKERS IN COVID-19 PNEUMONIA
por: GO, R., et al.
Publicado: (2022)

COVID-19 PNEUMONIA: A CAUSE OF CAVITARY LUNG LESIONS
por: ANIS, KARIM H, et al.
Publicado: (2022)

A PATIENT WITH COVID-19 PNEUMONIA, PULMONARY EMBOLISM, AND OSA
por: SPACONE, ANTONELLA, et al.
Publicado: (2022)

THE ROLE OF ASCORBIC ACID IN REDUCING MORTALITY IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: KHOKHER, WALEED, et al.
Publicado: (2021)

A COMPARISON OF THE INCIDENCE OF VENTILATOR-ASSOCIATED PNEUMONIA AMONG PATIENTS WITH COVID-19 AND INFLUENZA PNEUMONIA A AND B
por: GROSSMAN, J., et al.
Publicado: (2022)

FIRST CASE OF COVID-19 COMPLICATED WITH BURKOLDERIA CEPACIA PNEUMONIA AND BACTEREMIA
por: Osman, Heba, et al.
Publicado: (2020)

LATENT MYCOBACTERIUM TB REACTIVATION IN TWO PATIENTS WITH COVID-19 PNEUMONIA
por: YOUNES, ISLAM, et al.
Publicado: (2021)

CASE SERIES OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN POST-COVID-19 DISEASE
por: AYUB, MAAHA, et al.
Publicado: (2021)

SPIROMETRY IN COVID-19 PNEUMONIA PATIENTS ON CONTINUOUS REMOTE PATIENT MONITORING
por: LOUDERMILK, KEVIN, et al.
Publicado: (2021)

SEVERE COVID-19 PNEUMONIA IN A FULLY VACCINATED IMMUNOCOMPROMISED PATIENT
por: SUBRAMANIAN, LAKSHMI, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS AND OUTCOME OF PNEUMOMEDIASTINUM AND PNEUMOTHORAX IN PATIENTS WITH COVID-19 PNEUMONIA
por: RANA, VISHAL, et al.
Publicado: (2021)

CORRELATIONS BETWEEN VIRAL LOAD AND SYMPTOMS IN PATIENTS WITH COVID-19 PNEUMONIA
por: CAPITELLI, L., et al.
Publicado: (2022)

PNEUMATOCELE FORMATION FOLLOWING COVID-19 PNEUMONIA: A CASE REPORT
por: HASAN, M.M., et al.
Publicado: (2022)

A RARE CASE OF TRIPLE PNEUMONIA: TB, COCCIDIOIDOMYCOSIS, AND COVID-19
por: SINGH, H., et al.
Publicado: (2022)

AN UNUSUAL CASE OF COVID-19 COMPLICATED BY POSSIBLE ACUTE EOSINOPHILIC PNEUMONIA
por: ELSHAKH, HADYA, et al.
Publicado: (2022)

COVID-19 PNEUMONIA COMPLICATED BY EXACERBATION OF NEW DIAGNOSIS OF MYASTHENIA GRAVIS
por: SYED, AHSAN, et al.
Publicado: (2022)

30-DAY AND 90-DAY OUTCOMES OF THE SURVIVORS OF COVID-19 PNEUMONIA TREATED EXCLUSIVELY WITH CPAP: RESULTS FROM A DISTRICT TEACHING HOSPITAL
por: OKPO, ERNEST, et al.
Publicado: (2021)

D-DIMER AS A SURROGATE MARKER OF DISEASE SEVERITY IN AFRICAN AMERICAN POPULATION WITH COVID-19 PNEUMONIA: A COMMUNITY HOSPITAL RETROSPECTIVE STUDY
por: OMORE, IBRAHIM, et al.
Publicado: (2021)

A COMPARISON OF TWO CASES PRESENTING WITH HEMOPTYSIS ATTRIBUTABLE TO COVID-19 PNEUMONIA
por: OGUNLEYE, OLUSHOLA, et al.
Publicado: (2021)

ENDEMIC IN THE PANDEMIC: MURINE TYPHUS MASKING AS COVID-19 PNEUMONIA WITH PROFOUND HYPOXEMIA
por: LAVERE, PHILIP, et al.
Publicado: (2021)

EXERCISE CAPACITY AND HEALTH-RELATED QUALITY OF LIFE IN SURVIVORS OF COVID-19 PNEUMONIA
por: ROSS DAVID, JAMAICA, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_127k1keqen0vs27hvimtpgv3ai